Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$268K Buy
763
+5
+0.7% +$1.78K 0.15% 139
2025
Q4
$248K Buy
758
+6
+0.8% +$1.9K 0.13% 147
2025
Q3
$212K Sell
752
-8
-1% -$2.32K 0.12% 159
2025
Q2
$212K Sell
760
-123
-14% -$34.8K 0.16% 129
2025
Q1
$230K Hold
883
0.15% 145
2024
Q4
$230K Buy
+883
New +$262K 0.15% 145

Other funds holding AMGN

Claris Financial's AMGN Position: Q1 2026 in Review

Claris Financial increased its Amgen (AMGN) stake by 0.66% in Q1 2026, buying an estimated $1.78K and bringing the position to 763 shares worth $268K. The position accounts for 0.15% of the portfolio, ranked #139.

Claris Financial first reported a position in AMGN in Q4 2024 and has held it in 6 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Claris Financial held 763 shares of Amgen worth $268K as of Q1 2026.
  • Claris Financial bought 5 Amgen shares in Q1 2026, an estimated $1.78K.
  • Amgen made up 0.15% of Claris Financial's portfolio in Q1 2026, its #139 holding.
  • Claris Financial first reported a position in Amgen in Q4 2024 and has held it in 6 quarters since.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Claris Financial's 13F filing for Q1 2026, filed 18 May 2026.